Abselion
Life Sciences • South East • Early Stage
Abselion develops automated analytical instrumentation, to simplify at-line protein quantification. Its award-winning Amperia system allows scientists to quantify antibodies, AAVs and other proteins from crude samples, in as little as one minute.
Company
information
Investment date
March 2021
Head office
Cambridge